Worldwide: Life Sciences, Biotechnology & Nanotechnology

The OECD has released two groundbreaking test guidelines specifically designed for nanomaterials, addressing critical gaps in standardized testing methods for dustiness determination and environmental fate assessment. These new protocols provide regulatory frameworks for measuring how nano-objects behave under various conditions, supporting decision-making processes across OECD member countries. The guidelines build upon existing OECD testing standards while introducing specialized methodologies tailored to

A European Patent Office Technical Board of Appeal decision examines when algorithmic features in medical monitoring systems can support inventive step claims. The case centers on a blood glucose variability measurement system where the technical effect depends critically on the observation period, raising fundamental questions about claim scope and technical contribution.

Arthur Cox's Life Sciences Outlook 2026 examines critical regulatory developments and strategic opportunities shaping Ireland's life sciences sector. The publication explores Ireland's EU Council Presidency and its potential impact on advancing key legislative initiatives including the Biotech Act I and medical device reforms. Industry leaders will find comprehensive analysis spanning pharmaceutical compliance, medtech regulation, data governance, M&A activity, and environmental considerations.

The Netherlands is poised to dramatically expand its foreign direct investment screening regime by adding six highly sensitive technology categories—including biotechnology, artificial intelligence, and nanotechnology...

When assessing the requirement for a procedural security, namely the question whether the Claimant has “sufficient means” to compensate the Defendant for the legal costs incurred in the proceedings, only the financial situation of the Claimant should be taken into consideration, but not the financial situation of the holding company behind the Claimant.

Registration of your company and medical devices in EUDAMED, the EU’s central database for medical devices, will become mandatory from the first half of 2026.

Gérard Haas et son équipe ont compilé pour vous les actualités clés afin de vous permettre de rester à jour sur les dernières tendances et évolutions des secteurs juridique et numérique.

Boehringer sought injunctive relief against Zentiva Portugal in respect of the launch of a generic version of its drug marketed as Ofev® (containing nintedanib used for treating chronic lung diseases).

The European Commission has published Draft Merger Guidelines consolidating two decades of enforcement practice into a single framework that emphasizes dynamic competition, innovation, and ecosystem effects. While retaining the existing legal test, the guidelines articulate a more explicit analytical approach that brings greater prominence to scale, resilience, and non-price dimensions of competition, with particular implications for technology and life sciences transactions.